Yorktown Management & Research Company’s Insmed INSM Stock Holding History

Yorktown Management & Research Company’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$845K	Hold	7,925	–	–	0.52%	52
2026 Q1	$1.3M	Sell	7,925 -1,675	-17%	-$258K	1.08%	13
2025 Q4	$1.67M	Hold	9,600	–	–	1.34%	9
2025 Q3	$1.38M	Buy	9,600 +3,750	+64%	+$459K	1.1%	14
2025 Q2	$589K	Hold	5,850	–	–	0.56%	51
2025 Q1	$446K	Sell	5,850 -5,120	-47%	-$392K	0.49%	77
2024 Q4	$757K	Hold	10,970	–	–	0.73%	27
2024 Q3	$801K	Hold	10,970	–	–	0.82%	21
2024 Q2	$735K	Buy	+10,970	New	+$425K	0.79%	27

Other funds holding INSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Yorktown Management & Research Company's INSM Position: Q2 2026 in Review

Yorktown Management & Research Company held its Insmed (INSM) position steady in Q2 2026 at 7,925 shares worth $845K. The position accounts for 0.52% of the portfolio, ranked #52.

Yorktown Management & Research Company first reported a position in INSM in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.67M in Q4 2025. 281 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Yorktown Management & Research Company held 7,925 shares of Insmed worth $845K as of Q2 2026.
Yorktown Management & Research Company left its Insmed share count unchanged in Q2 2026.
Insmed made up 0.52% of Yorktown Management & Research Company's portfolio in Q2 2026, its #52 holding.
Yorktown Management & Research Company first reported a position in Insmed in Q2 2024 and has held it in 9 quarters since.
Yorktown Management & Research Company's Insmed position peaked at $1.67M in Q4 2025.
281 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Yorktown Management & Research Company's 13F filing for Q2 2026, filed 23 Jul 2026.